中华顶尖财经--信息搜索

信息搜索

信息关键字：医

『查询2022年信息』『查询2021年信息』『查询2020年信息』『查询2019年信息』『查询2018年信息』『查询2017年信息』『查询2016年信息』
『查询2015年信息』『查询2014年信息』『查询2013年信息』『查询2012年信息』『查询2011年信息』『查询2010年信息』『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165]

·复星医药：控股子公司获药品临床试验批准2023-11-20 19:13:13

·医药与健康护理行业周报：2023年国家医保谈判工作正式启动，关注创新药及具备性价比的大药企2023-11-20 18:41:24

·医药生物行业周报：医保谈判进行时，关注大产品受益医保快速放量标的2023-11-20 17:22:05

·仟源医药（300254）11月20日主力资金净买入1382.77万元2023-11-20 17:05:36

·多瑞医药：全资子公司获得药品注册证书2023-11-20 16:52:10

·社会服务行业周报：关注医美护肤协同趋势，冰雪和出境需求释放2023-11-20 16:44:05

·医美化妆品10月月报：三季报披露完毕，关注双11大促表现亮眼的国货美妆龙头品牌2023-11-20 16:19:02

·接连签约核药、手术导航创新产品！百洋医药商业化平台创新发展全面提速2023-11-20 15:38:11

·港股互联网医疗概念股震荡走高京东健康涨超5%2023-11-20 14:25:09

·医药生物行业周报：医保谈判揭晓在即，需关注具备创新品类的标的2023-11-20 13:59:46

·医药生物行业周报：创新出海打开市场空间，海外高壁垒筛选优秀标的2023-11-20 13:47:17

·医药行业周报：持续看好创新药出海2023-11-20 13:35:01

·医药生物行业周报：关注边际改善，以及关注主题催化2023-11-20 13:22:21

·医药生物行业周报：第九批集采中选结果出炉，仿制药行业迎接新拐点2023-11-20 12:53:02

·上海医药：周军辞去董事长等职务2023-11-20 12:02:57

·迈瑞医疗（300760）11月17日主力资金净买入2570.96万元2023-11-20 11:46:22

·十大券商策略：A股或将峰回路转！关键事件性催化已落地关注大金融和医药2023-11-20 9:03:07

·上海医药：因个人原因，周军辞去董事长等职务2023-11-20 8:09:39

·国家药监局共批准上市创新医疗器械237个2023-11-19 20:40:59

·医药生物行业跟踪周报：药店资产处于估值低、位置低，看好其2024年超额收益2023-11-19 18:24:33

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165]